Niklas Papenkordt

7PUBLICATIONS
50CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsBiologically active moleculesContaminant hydrologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 05, 2026
Development of High-Affinity CHD1 Chromodomain Inhibitors.

|Oct 30, 2025
From Pharmacophore to Warhead: NAD+-Targeting Triazoles as Mechanism-Based Sirtuin Inhibitors.

Florian Friedrich, Marat Meleshin, Niklas Papenkordt

|Sep 08, 2025
Tailored SirReal-type inhibitors enhance SIRT2 inhibition through ligand stabilization and disruption of NAD+ co-factor binding.

Ricky Wirawan, Matthias Frei, Anna Heider

|Nov 11, 2024
Aromatic Amino Acid Hydroxylases as Off-Targets of Histone Deacetylase Inhibitors.

Anne Baumann, Niklas Papenkordt, Dina Robaa

|Oct 30, 2023
Development of First-in-Class Dual Sirt2/HDAC6 Inhibitors as Molecular Tools for Dual Inhibition of Tubulin Deacetylation.

Laura Sinatra, Anja Vogelmann, Florian Friedrich

|Jun 20, 2023
Melatonin-vorinostat hybrid ligands show higher histone deacetylase and cancer cell growth inhibition than vorinostat.

Youssef Y Helmi, Niklas Papenkordt, Georg Rennar

Pageof 2

Frequent Collaborators

7 joint publications

Manfred Jung

3 joint publications

Florian Friedrich

3 joint publications

Wolfgang Sippl

2 joint publications

Jan Ruprecht